title: Cetuximab in the Context of Current Treatment of Squamous Cell Carcinoma of the Anus.
authors.affiliation: Rob Glynne-Jones and Mark Harrison, Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, United Kingdom.
authors.forename: Rob
authors.initials: R
authors.lastname: Glynne-Jones
authors.affiliation: Rob Glynne-Jones and Mark Harrison, Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, United Kingdom.
authors.forename: Mark
authors.initials: M
authors.lastname: Harrison
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D000068818:Cetuximab / Q000009:adverse effects / Q000627:therapeutic use*; D059248:Chemoradiotherapy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D016896:Treatment Outcome
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000068818:Cetuximab